Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander reported shared voting and dispositive power over 4,567,952 shares of Relmada Therapeutics common stock, representing 4.4% of the class. The cover pages show the position linked to actions around 06/16/2026 and the filing states the reporting persons "ceased to be beneficial owners of more than 5% of the outstanding Common Stock by the date of this filing." The filing includes a Joint Filing Agreement dated June 18, 2026.
Positive
None.
Negative
None.
Insights
Reports a non‑controlling 4.4% shared position with a joint filing.
The filing lists shared voting and shared dispositive power over 4,567,952 shares as shown on the cover pages and ties those holdings to entities under common control. The statement that the reporting persons "ceased to be beneficial owners of more than 5%" is included verbatim.
Key dependencies include the holdings held by affiliated entities and the Joint Filing Agreement dated June 18, 2026. Subsequent SEC schedules could update ownership if dispositions or acquisitions occur.
Routine 13G disclosure showing a passive, sub‑5% position after prior acquisition activity.
The schedule indicates the reporting persons acquired and then reduced a >5% stake to 4,567,952 shares (4.4%), per Item 4 language. The filing’s mechanics are governed by the joint filing among the three reporting persons.
Cash‑flow treatment and具体 trading methods are not stated in the excerpt; further filings would show any material changes to holdings or voting arrangements.
Key Figures
Shared dispositive/voting power:4,567,952 sharesPercent of class:4.4%Date of acquisition >5%:06/16/2026+1 more
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
shared dispositive powerfinancial
"Cover page columns showing shared dispositive power of 4,567,952"
Joint Filing Agreementlegal
"Exhibit I: Joint Filing Agreement, dated as of June 18, 2026"
What stake did Millennium report in Relmada (RLMD)?
They report shared voting and dispositive power over 4,567,952 shares, representing 4.4% of the common stock, per the cover pages and Item 11.
When did the reporting persons exceed and then fall below 5% in RLMD?
The filing states they acquired beneficial ownership of more than 5% on 06/16/2026 and "ceased to be beneficial owners of more than 5% by the date of this filing."
Who are the reporting persons on the Schedule 13G for RLMD?
The reporting persons are Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, per Item 2 and the signature block.
Does the filing show sole control of the shares?
No. The cover pages and Item 5–8 show 0 sole voting/dispositive power and 4,567,952 in shared voting and shared dispositive power.
Is there an agreement among the filers?
Yes. The filing includes a Joint Filing Agreement dated June 18, 2026 among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Relmada Therapeutics, Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
75955J402
(CUSIP Number)
06/16/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
75955J402
1
Names of Reporting Persons
Millennium Management LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,567,952.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,567,952.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,567,952.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.4 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
75955J402
1
Names of Reporting Persons
Millennium Group Management LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,567,952.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,567,952.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,567,952.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.4 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
75955J402
1
Names of Reporting Persons
Israel A. Englander
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,567,952.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,567,952.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,567,952.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.4 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Relmada Therapeutics, Inc.
(b)
Address of issuer's principal executive offices:
2222 Ponce de Leon Blvd., Floor 3, Coral Gables, Florida 33134
Item 2.
(a)
Name of person filing:
Millennium Management LLC
Millennium Group Management LLC
Israel A. Englander
(b)
Address or principal business office or, if none, residence:
Millennium Management LLC
399 Park Avenue
New York, New York 10022
Millennium Group Management LLC
399 Park Avenue
New York, New York 10022
Israel A. Englander
c/o Millennium Management LLC
399 Park Avenue
New York, New York 10022
(c)
Citizenship:
Millennium Management LLC - Delaware
Millennium Group Management LLC - Delaware
Israel A. Englander - United States
(d)
Title of class of securities:
Common Stock, par value $0.001 per share
(e)
CUSIP Number(s):
75955J402
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
See response to Item 9 on each cover page.
After acquiring beneficial ownership of more than 5% of the outstanding Common Stock on June 16, 2026, the reporting persons ceased to be beneficial owners of more than 5% of the outstanding Common Stock by the date of this filing.
(b)
Percent of class:
See response to Item 11 on each cover page.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See response to Item 5 on each cover page.
(ii) Shared power to vote or to direct the vote:
See response to Item 6 on each cover page.
(iii) Sole power to dispose or to direct the disposition of:
See response to Item 7 on each cover page.
(iv) Shared power to dispose or to direct the disposition of:
See response to Item 8 on each cover page.
The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
See Exhibit I
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Millennium Management LLC
Signature:
/s/ Gil Raviv
Name/Title:
Gil Raviv, Global General Counsel
Date:
06/18/2026
Millennium Group Management LLC
Signature:
/s/ Gil Raviv
Name/Title:
Gil Raviv, Global General Counsel
Date:
06/18/2026
Israel A. Englander
Signature:
/s/ Israel A. Englander
Name/Title:
Israel A. Englander
Date:
06/18/2026
Exhibit Information
Exhibit I: Joint Filing Agreement, dated as of June 18, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.
